For the second consecutive year, The Atlantic, a magazine that has played a central role in shaping the national debate on current affairs and cultural trends for 150 years, has chosen to partner with UC San Diego to co-host a forum of national prominence on campus.
Computer scientists at the University of California, San Diego, the International Computer Science Institute at Berkeley and George Mason University have received a $10 million, five-year grant from the National Science Foundation to map out the illicit activities taking place in the cybersecurity underworld and to understand how the mind of a cybercriminal works.
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
UC San Diego Sulpizio Family Cardiovascular Center has received Modern Healthcare’s highest design honor, the 2012 Modern Healthcare Design Award. Out of more than one hundred entries, only one other project received this honor in 2012.
UC San Diego’s Center for Transplantation has met or exceeded all of its necessary requirements for approval as a center of excellence under the Federal Medicare program. This approval – from the Center for Medicare and Medicaid Services (CMS) – allows UC San Diego Health System to accept into its program potential cardiac transplant patients covered by Medicare.
Adah Almutairi, associate professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences, the department of nanoengineering, and the materials science and engineering program at the UC San Diego, and colleagues have developed the first degradable polymer that is extremely sensitive to low but biologically relevant concentrations of hydrogen peroxide.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
